Medicover AB Series B
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Servi… Read more
Medicover AB Series B (0RPS) - Total Liabilities
Latest total liabilities as of June 2025: Skr1.83 Billion SEK
Based on the latest financial reports, Medicover AB Series B (0RPS) has total liabilities worth Skr1.83 Billion SEK as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medicover AB Series B - Total Liabilities Trend (2014–2024)
This chart illustrates how Medicover AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medicover AB Series B Competitors by Total Liabilities
The table below lists competitors of Medicover AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Craftsman Automation Limited
NSE:CRAFTSMAN
|
India | ₹52.36 Billion |
|
Guangdong Sky Dragon Printing Ink Group Co Ltd
SHE:300063
|
China | CN¥1.65 Billion |
|
Hyundai Bioscience Co. Ltd
KQ:048410
|
Korea | ₩6.34 Billion |
|
Aptus Value Housing Finance India Limited
NSE:APTUS
|
India | ₹76.00 Billion |
|
Northern Data AG
PINK:NDTAF
|
USA | $819.46 Million |
|
Alliance Material Co., Ltd.
TWO:3595
|
Taiwan | NT$110.32 Million |
|
Eastcompeace Technology Co Ltd
SHE:002017
|
China | CN¥1.19 Billion |
|
Foran Mining Corporation
OTCQX:FMCXF
|
USA | $570.46 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Medicover AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.92 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medicover AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medicover AB Series B (2014–2024)
The table below shows the annual total liabilities of Medicover AB Series B from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr1.65 Billion | +16.69% |
| 2023-12-31 | Skr1.41 Billion | +6.97% |
| 2022-12-31 | Skr1.32 Billion | +17.71% |
| 2021-12-31 | Skr1.12 Billion | +78.87% |
| 2020-12-31 | Skr627.40 Million | -4.91% |
| 2019-12-31 | Skr659.80 Million | +129.66% |
| 2018-12-31 | Skr287.30 Million | +43.79% |
| 2017-12-31 | Skr199.80 Million | -37.70% |
| 2016-12-31 | Skr320.70 Million | +46.04% |
| 2015-12-31 | Skr219.60 Million | +22.61% |
| 2014-12-31 | Skr179.10 Million | -- |